Addex Therapeutics Ltd ADR (ADXN) Stock Price, Quote & News

Company Profile

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate re...

Industry: Biotechnology

Sector: Healthcare

Phone: 41 22 884 1555

Fax: 41 22 884 1556

Website: www.addextherapeutics.com

Address:

Chemin des Mines, 9, Geneva, Switzerland

DegeneratePeter Sep. 13 at 6:18 AM

MITQ my top watch for next week, I think market will send this up 100%-200%+ already near 52 weeks high, After that it's gonna be a sweet squeeze imo. $ADXN $CMCT $BHST $AISP Watching.

1 · Reply

SeekAndFind2020 Sep. 13 at 2:37 AM

$ADXN $GCTK $BGSF $HCWB don;t believe this shit scammer, he doesn't trade any stocks, everyday post , professional scammer

0 · Reply

CAPITALWHISPERER Sep. 12 at 11:33 PM

My TOP calls for TODAY ( Part -1- ) were : 1- $ADXN 8.15 - 22 2- $GCTK 8.20 - 14.49 3- $FOFO 5.45 - 14.90 4- $BGSF 6.65 - 10.79 5- $HCWB 4.10 - 8.52

0 · Reply

Pipelinepivots Sep. 12 at 9:20 PM

$ADXN $HCWB $HUIZ $SIDU MITQ’s setup is rare and ready. Golden cross. Real revenue. Low float. This could move faster than most expect.🙏🌙🚀🚀🚀🚀🚀🚀

0 · Reply

MomentumSpotter_ Sep. 12 at 8:31 PM

$ADXN $IBM $NU $PLRZ

0 · Reply

XkaliburTrading Sep. 12 at 6:59 PM

Hello everyone followers and Team! Good Friday it is! Almost the end of the week here, so lets finish this week off right to start the weekend off properly! So far the Team and I spotted these today at... (Part 3) $OPI at 0.448 hod so far at 0.778 💪 $ADXN at 12.01 hod so far at 21.99 🫡

1 · Reply

Markstockguy Sep. 12 at 6:56 PM

$ASST $AMBR $ADXN CHUC is up 800% since March. And it is projected to increase another 15X over the next 12 months. The company is PROFTABLE. And GROWING. (No worries about dilutive financings here.) Almost half the company is owned by insiders… one director bought THIS WEEK, at close to the 52-week high. CHUC’s products are a good alternative for adult smokers. CHUC’s stock is a GREAT choice for intelligent investors. Find out why! Do your own due diligence.

1 · Reply

MrMaxxxx Sep. 12 at 6:37 PM

$ADXN She is just getting started. Weak hands are selling. A close above $11.02 is very very bullish. I look for a run after hour.

1 · Reply

KyngOchoa Sep. 12 at 5:55 PM

$ADXN NXXT PT five to six looks conservative with momentum like this 📈 valuation gap versus peers is wide

0 · Reply

StMartinBr Sep. 12 at 5:45 PM

$ADXN show is over guys

1 · Reply

Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs

Jun 30, 2025, 1:00 AM EDT - 2 months ago

Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders

Jun 25, 2025, 1:00 AM EDT - 2 months ago

Addex Shareholders Approve All Resolutions at Annual General Meeting

Jun 19, 2025, 1:00 AM EDT - 3 months ago

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

Jun 18, 2025, 1:00 AM EDT - 3 months ago

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Jun 6, 2025, 1:00 AM EDT - 3 months ago

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Jun 3, 2025, 1:00 AM EDT - 3 months ago

Addex Convenes Annual General Meeting 2025

May 12, 2025, 1:00 AM EDT - 4 months ago

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

Apr 30, 2025, 1:00 AM EDT - 4 months ago

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

Apr 25, 2025, 4:40 PM EDT - 5 months ago

Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript

Apr 25, 2025, 1:00 AM EDT - 5 months ago

Addex Reports Full Year 2024 Financial Results and Provides Corporate Update

Apr 17, 2025, 1:00 AM EDT - 5 months ago

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

Jan 8, 2025, 1:00 AM EST - 8 months ago

Addex to Present at the 2025 Swiss Equities Baader Conference

Nov 22, 2024, 11:11 AM EST - 10 months ago

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript

Nov 22, 2024, 1:00 AM EST - 10 months ago

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 11, 2024, 1:00 AM EST - 10 months ago

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

Sep 30, 2024, 12:04 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript

Sep 30, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

Sep 19, 2024, 1:00 AM EDT - 1 year ago

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Sep 4, 2024, 1:00 AM EDT - 1 year ago

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 12:03 PM EDT - 1 year ago

Crude Oil Dips; Addex Therapeutics Shares Spike Higher

Aug 27, 2024, 10:47 AM EDT - 1 year ago

Why Addex Therapeutics stock skyrocketed 70% on Tuesday

Aug 27, 2024, 1:00 AM EDT - 1 year ago

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

Jul 22, 2024, 1:00 AM EDT - 1 year ago

Addex's Partner Discontinues ADX71149 development in Epilepsy

Jul 15, 2024, 1:00 AM EDT - 1 year ago

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

Jul 12, 2024, 1:00 AM EDT - 1 year ago

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

Jun 6, 2024, 12:50 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q1 2024 Earnings Call Transcript

Jun 6, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

Jun 5, 2024, 1:00 AM EDT - 1 year ago

Addex Convenes Annual General Meeting 2024

May 31, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

May 8, 2024, 1:00 AM EDT - 1 year ago

Addex to Present at Bio€quity Europe 2024

Apr 29, 2024, 1:00 AM EDT - 1 year ago

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Apr 19, 2024, 1:00 AM EDT - 1 year ago

Addex to Present at the Swiss Biotech Day 2024

Apr 18, 2024, 1:46 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript

Apr 18, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update

Apr 11, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Apr 3, 2024, 1:00 AM EDT - 1 year ago

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Mar 14, 2024, 2:00 AM EDT - 1 year ago

Addex to Present at the Bio-Europe Spring 2024 Conference

Jan 31, 2024, 1:00 AM EST - 1 year ago

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

Jan 9, 2024, 1:00 AM EST - 1 year ago

Addex to Present at the Swiss Equities Baader Conference

Jan 5, 2024, 1:30 AM EST - 1 year ago

Addex to Present at Biotech Showcase™ 2024

Dec 20, 2023, 1:00 AM EST - 1 year ago

Addex Shareholders Approve All Resolutions at Extraordinary General Meeting

Dec 14, 2023, 1:00 AM EST - 1 year ago

Addex Creates Treasury Shares

Nov 29, 2023, 1:41 PM EST - 1 year ago

Addex Therapeutics Ltd (ADXN) Q3 2023 Earnings Call Transcript

Nov 29, 2023, 1:00 AM EST - 1 year ago

Addex Reports Q3 2023 Financial Results and Provides Corporate Update

Nov 28, 2023, 1:00 AM EST - 1 year ago

Addex Convenes Extraordinary General Meeting

Nov 23, 2023, 1:00 AM EST - 1 year ago

Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023

Nov 14, 2023, 1:00 AM EST - 1 year ago

Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients

Nov 8, 2023, 1:00 AM EST - 2 years ago

Addex Regains Nasdaq Listing Compliance

Nov 2, 2023, 2:00 AM EDT - 2 years ago

Addex Announces Participation in the Bio-Europe 2023 Conference

DegeneratePeter Sep. 13 at 6:18 AM

MITQ my top watch for next week, I think market will send this up 100%-200%+ already near 52 weeks high, After that it's gonna be a sweet squeeze imo. $ADXN $CMCT $BHST $AISP Watching.

1 · Reply

SeekAndFind2020 Sep. 13 at 2:37 AM

$ADXN $GCTK $BGSF $HCWB don;t believe this shit scammer, he doesn't trade any stocks, everyday post , professional scammer

0 · Reply

CAPITALWHISPERER Sep. 12 at 11:33 PM

My TOP calls for TODAY ( Part -1- ) were : 1- $ADXN 8.15 - 22 2- $GCTK 8.20 - 14.49 3- $FOFO 5.45 - 14.90 4- $BGSF 6.65 - 10.79 5- $HCWB 4.10 - 8.52

0 · Reply

Pipelinepivots Sep. 12 at 9:20 PM

$ADXN $HCWB $HUIZ $SIDU MITQ’s setup is rare and ready. Golden cross. Real revenue. Low float. This could move faster than most expect.🙏🌙🚀🚀🚀🚀🚀🚀

0 · Reply

MomentumSpotter_ Sep. 12 at 8:31 PM

$ADXN $IBM $NU $PLRZ

0 · Reply

XkaliburTrading Sep. 12 at 6:59 PM

1 · Reply

Markstockguy Sep. 12 at 6:56 PM

1 · Reply

MrMaxxxx Sep. 12 at 6:37 PM

$ADXN She is just getting started. Weak hands are selling. A close above $11.02 is very very bullish. I look for a run after hour.

1 · Reply

KyngOchoa Sep. 12 at 5:55 PM

$ADXN NXXT PT five to six looks conservative with momentum like this 📈 valuation gap versus peers is wide

0 · Reply

StMartinBr Sep. 12 at 5:45 PM

$ADXN show is over guys

1 · Reply

AE4328 Sep. 12 at 4:48 PM

$ADXN look it is waking up

0 · Reply

KyngOchoa Sep. 12 at 4:42 PM

$ADXN NXXT classic buy the base setup risk defined reward loaded buyers ready to press over two and stretch higher 🎯

0 · Reply

Am1232 Sep. 12 at 4:28 PM

$ADXN

1 · Reply

laurenlee Sep. 12 at 4:19 PM

$ADXN when?

1 · Reply

MomentumZeus Sep. 12 at 4:07 PM

Congrats if you banked on $ADXN last night! From $9 to $22 high this morning! Over 120%+ potential profits! Looks like markets are crazy bullish right now! This post gets 30 likes and I'll drop another potential 100%+ runner!

3 · Reply

tommy45 Sep. 12 at 3:47 PM

$ADXN small position just sold for a weekend getaway see you guys always take profit when you can gl to every one

0 · Reply

UgoGreg Sep. 12 at 3:38 PM

$ADXN https://youtu.be/PPEi4Qf0jak

0 · Reply

topstockalerts Sep. 12 at 3:31 PM

$ADXN this setup continues to provide opportunities.. stay tuned!

1 · Reply

Winner4Ever Sep. 12 at 3:26 PM

$ADXN I only bought 100 shares but I thought it was going to go up a lot today

1 · Reply

Prism_Fall_67 Sep. 12 at 3:16 PM

$ADXN NXXT bulls loading before lift off bids stacked support sturdy chart tightening like a coiled spring 🪙

0 · Reply

laurenlee Sep. 12 at 3:06 PM

$ADXN Nice private pump and dump

0 · Reply

laurenlee Sep. 12 at 3:00 PM

$ADXN I believe it’s a team of pumpers, but that’s just me

0 · Reply

Market Cap	8.37M
Revenue (ttm)	460,000.00
Net Income (ttm)	8.01M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	1,741.30%
Debt to Equity Ratio	0.00

Volume	741
Avg Vol	8,018
Day's Range	N/A - N/A
Shares Out	1.06M
Stochastic %K	32%
Beta	1.63
Analysts	Strong Buy
Price Target	$30.00